RESIKALI, powder for suspension oral/rectal
Active ingredients: Calcium polystyrene sulfonate
Commercialized according to BDPMDispensing in France: Prescription only
Powder for suspension1 récipient(s) multidose(s) polyéthylène de 500 g avec cuillère-mesure polystyrèneorale;rectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RESIKALI, poudre pour suspension orale/rectale
- Pharmaceutical form
- poudre pour suspension ou
- Route of administration
- orale;rectale
- Presentation description
- 1 récipient(s) multidose(s) polyéthylène de 500 g avec cuillère-mesure polystyrène
- Marketing authorisation holder
- FRESENIUS MEDICAL CARE NEPHROLOGICA DEUTSCHLAND
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Jan 2010
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63815331CIP73804986CIP133400938049862Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| POLYSTYRÈNE SULFONATE DE CALCIUMpoudre | 759-949 mg · 1 g de poudre | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.